Medistim ASA (OSL:MEDI)
Norway · Delayed Price · Currency is NOK 231.00
-4.00 (-1.70%)
May 15, 2026, 1:58 PM CET
Medistim ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 719.89 | 699.77 | 562.6 | 526.36 | 491.94 | 427.28 | |
Revenue Growth (YoY) | 17.95% | 24.38% | 6.88% | 7.00% | 15.13% | 17.66% |
Cost of Revenue | 138.84 | 128.17 | 113.68 | 112.28 | 106.49 | 97.11 |
Gross Profit | 581.05 | 571.59 | 448.92 | 414.08 | 385.45 | 330.16 |
Selling, General & Admin | 230.82 | 230.34 | 185.11 | 162.6 | 146.38 | 134.51 |
Depreciation & Amortization Expenses | 25.48 | 24.83 | 24.51 | 23.66 | 23.29 | 23.43 |
Other Operating Expenses | 130.64 | 120.23 | 108.22 | 96.39 | 74.54 | 55.95 |
Total Operating Expenses | 386.94 | 375.4 | 317.84 | 282.64 | 244.2 | 213.88 |
Operating Income | 194.11 | 196.2 | 131.08 | 131.44 | 141.25 | 116.28 |
Interest Income | 28.36 | 27.5 | 11.5 | 17.12 | 16.55 | 8.17 |
Interest Expense | -20.81 | -16.85 | -8.33 | -13.35 | -11.75 | -10.38 |
Total Non-Operating Income (Expense) | 7.55 | 10.65 | 3.17 | 3.77 | 4.8 | -2.21 |
Pretax Income | 201.66 | 206.85 | 134.25 | 135.21 | 146.05 | 114.07 |
Provision for Income Taxes | 45.58 | 47.64 | 30.41 | 31.39 | 32.08 | 23.17 |
Net Income | 156.08 | 159.21 | 103.83 | 103.82 | 113.97 | 90.9 |
Net Income to Common | 156.08 | 159.21 | 103.83 | 103.82 | 113.97 | 90.9 |
Net Income Growth | 27.02% | 53.33% | 0.01% | -8.91% | 25.38% | 31.00% |
Shares Outstanding (Basic) | 18 | 18 | 18 | 18 | 18 | 18 |
Shares Outstanding (Diluted) | 18 | 18 | 18 | 18 | 18 | 18 |
Shares Change (YoY) | -0.21% | -0.21% | 0.10% | 0.10% | 0.15% | 0.07% |
EPS (Basic) | 8.53 | 8.71 | 5.67 | 5.68 | 6.25 | 4.99 |
EPS (Diluted) | 8.53 | 8.71 | 5.67 | 5.67 | 6.24 | 4.98 |
EPS Growth | 27.12% | 53.62% | - | -9.13% | 25.30% | 31.05% |
Shares Outstanding | 18.29 | 18.34 | 18.34 | 18.34 | 18.34 | 18.23 |
Free Cash Flow | 179.97 | 171.56 | 137.04 | 102.8 | 104.24 | 119.97 |
Free Cash Flow Growth | 4.91% | 25.19% | 33.30% | -1.38% | -13.11% | 79.91% |
Free Cash Flow Per Share | 9.85 | 9.39 | 7.48 | 5.62 | 5.70 | 6.57 |
Dividends Per Share | 8.000 | 8.000 | 6.000 | 4.500 | 4.500 | 3.750 |
Dividend Growth | - | 33.33% | 33.33% | - | 20.00% | 25.00% |
Gross Margin | 80.71% | 81.68% | 79.79% | 78.67% | 78.35% | 77.27% |
Operating Margin | 26.96% | 28.04% | 23.30% | 24.97% | 28.71% | 27.21% |
Profit Margin | 21.68% | 22.75% | 18.46% | 19.72% | 23.17% | 21.27% |
FCF Margin | 25.00% | 24.52% | 24.36% | 19.53% | 21.19% | 28.08% |
EBITDA | 192.61 | 212.21 | 146.47 | 155.1 | 164.54 | 139.71 |
EBITDA Margin | 26.76% | 30.33% | 26.03% | 29.47% | 33.45% | 32.70% |
EBIT | 194.11 | 196.2 | 131.08 | 131.44 | 141.25 | 116.28 |
EBIT Margin | 26.96% | 28.04% | 23.30% | 24.97% | 28.71% | 27.21% |
Effective Tax Rate | 22.60% | 23.03% | 22.66% | 23.21% | 21.96% | 20.31% |
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.